July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Petros Grivas: No role of anti-PD(L)1 rechallenge in RCC
May 13, 2025, 02:24

Petros Grivas: No role of anti-PD(L)1 rechallenge in RCC

Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington and Seattle Cancer Care Alliance, shared a post on X:

“Great talk by my colleague Scott Tykodi on RCC! Adjuvant pembro prolongs OS; 1L Ipi/nivo durable benefit in some patients with 99-month median follow up; no role of anti-PD(L)1 rechallenge based on Contact03 and TiNivo2 trials.”

Petros Grivas